About Molecular Products
Molecular Products is a company based in Harlow (United Kingdom) founded in 1924, and was acquired by Filtration Group in June 2021. Products for pollutant gas filtration are manufactured and distributed. Molecular Products has raised $6.54 million across 1 funding round from investors including Filtration Group, BGF and Arlington Capital Partners. Molecular Products has completed 1 acquisition, including OC Lugo. Its chief executive, as recorded, is Troy Rhudy. Molecular Products offers products and services including Sofnolime and Impregnated Activated Carbons. Its legal entity is Molecular Products Inc.
Company details
Molecular Products was established in 1924 and is headquartered in Harlow, United Kingdom. Operations are centered in the manufacturing sector, where filtration products for pollutant gases are developed and produced. These solutions are applied across industrial settings to address gas purification needs. The company is led by CEO Troy Rhudy, with activities spanning product innovation and supply to global markets.
- Headquarters Harlow, United Kingdom
- Stage Acquired
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website molecularproducts.com
- Social LinkedIn X
- Acquired by Filtration Group (Jun 2021)
- Legal Name Molecular Products Inc
- Total Equity Funding$6.54M (USD)
in 1 rounds
- Latest Funding Round$6.54M (USD), Series B
Sep 2014
- InvestorsFiltration Group
& 2 more
- Investments & Acquisitions
- Acquired by
Products & Services of Molecular Products
Molecular Products offers a comprehensive portfolio of products and services, including Sofnolime and Impregnated Activated Carbons.
Sofnolime is utilized as a carbon dioxide absorbent in diving and hyperbaric systems to maintain breathable atmospheres in sealed environments.
These are manufactured for critical air purification in industrial, defense, and nuclear applications to ensure the removal of harmful emissions.
Funding Insights of Molecular Products
Molecular Products has successfully raised a total of $6.54M through 1 strategic funding round. The most recent funding activity was a Series B round of $6.54 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.54M
- Total Rounds 1
- Last Round Series B β $6.54M
- First Round $6.54M
(Sep 2014)
- Investors Count 1
All 1 funding rounds of Molecular Products with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $6.54M | Series B | β | β |
3 investors in total: 3 institutional.
Investors in Molecular Products
Molecular Products has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Filtration Group, BGF and Arlington Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland | bgf.co.uk | Belfast, United Kingdom | ||
Private equity firm focused on investments in regulated industries. | arlingtoncap.com | |||
Filtration products and solutions are manufactured for diverse industries. | 1942 | filtrationgroup.com | Austin, United States |
Investor details for Molecular Products
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Molecular Products
16 people are tracked at Molecular Products (8 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Troy Rhudy | CEO | Leadership |
Paul Flowers | Managing Director | Leadership |
Lisa Keilthy Fcma | Director Of Finance | Leadership |
Brandon Smith | Chief Financial Officer | Leadership |
Joseph Carloto | Chief Financial Officer/operating Partner | Leadership |
Vikrant Patil | Country Head - India. | Leadership |
Mark Jarvis | Director Of Engineering | Leadership |
Ruben C. | Director Of Quality Assurance And Regulatory Affairs | Leadership |
Tony de Viveiros de M. Franca | Quality Control Laboratory Manager | Team |
Kevin B. McBride | Financial Controller | Team |
Mohamed Kasmani | Financial Controller | Team |
Jessica A. | Senior Accountant | Team |
Joseph P. Ciccone | Soda Lime Expert & Op-cat Dabbler | Team |
Natalie Gorton | Chemical Engineer | Team |
Matt Boucher | Plant Manager | Team |
Justin Rogers | Line Manager | Team |
Complete people profiles for Molecular Products
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Products
Molecular Products has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OC Lugo.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
RG and transition metal catalysts are manufactured by the company. | oclugo.com | Nyack, United States | 1973 | Nov 2019 | β’β’β’β’ |
Complete acquisition details for Molecular Products
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Molecular Products
5 dated milestones of Molecular Products across 97 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Products is founded.
- Funding First funding round of $6.5M.
- Exit Acquired by Arlington Capital Partners.
- Acquisition Acquires OC Lugo.
- Exit Acquired by Filtration Group.
Web traffic of Molecular Products
The website of Molecular Products (molecularproducts.com) receives about 4.2K visits a month.
- Monthly visits4.2K
▼ 27% vs previous month
Websites whose visitors overlap most with Molecular Products. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
minearc.com | minearc.com | 100% | #1,534,944 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Products
Molecular Products was founded in 1924 and raised its 1st funding round 90 years after it was founded.
Molecular Products is headquartered in Harlow, United Kingdom. It is registered at Harlow, Essex, United Kingdom.
Troy Rhudy is the CEO of Molecular Products, as recorded in our data.
Molecular Products is a funded company, having raised a total of $6.54M across 1 funding round to date. The company's 1st funding round was a Series B of $6.54M, raised on Sep 2014.
Molecular Products was established in 1924 and is headquartered in Harlow, United Kingdom. Operations are centered in the manufacturing sector, where filtration products for pollutant gases are developed and produced. These solutions are applied across industrial settings to address gas purification needs. The company is led by CEO Troy Rhudy, with activities spanning product innovation and supply to global markets.
Molecular Products offers Sofnolime and Impregnated Activated Carbons.
Molecular Products has made 1 acquisition, including OC Lugo.
Molecular Products has 3 investors. Key investors include Filtration Group, BGF, and Arlington Capital Partners.
Molecular Products operates through Molecular Products Inc.
Yes. Molecular Products was acquired by Filtration Group in June 2021.
